About
Frank Jessen received his MD degree from the University of Saarland in 1995. After residencies in neuropathology at the University of Düsseldorf, and neurology and psychiatry at the University of Bonn, he was board certified as a psychiatrist and psychotherapist in 2002. He served from 2002-2010 as a consultant psychiatrist and head of clinical Alzheimer’s disease research at the Department of Psychiatry, University of Bonn. In 2010, he was appointed Professor of Clinical Dementia Research and deputy director of the Department of Psychiatry, University of Bonn. In 2015, he was appointed as a Professor of Psychiatry and Psychotherapy and director of the Department of Psychiatry, University of Cologne. Since 2010, he is an associate researcher and group leader for Clinical Alzheimer Research at the German Center of Neurogenerative Diseases (DZNE).
Frank’s research focusses on prevention, early diagnosis and treatment of Alzheimer’s disease with expertise in neuropsychology, neuroimaging, epidemiology and genetics. He coordinated national and international multicenter observational studies and clinical trials. He is a member of the board of the Germany Psychiatric Association (DGPPN), for which he coordinates the German national guideline on the diagnosis and treatment of dementia (S3-guideline dementia).
He is a member of the DZNE clinical board, chair of the European Alzheimer’s Disease Consortium (EADC) and member the NIA-AA working group on Alzheimer’ s disease criteria. He is the founder and past chairman of the ISTARRT professional interest area on subjective cognitive decline (SCD) and the SCD-initiative (SCD-I). In Germany, he is the founder and chair of the German Memory Clinic Network (DNG) and serves on the scientific advisory board of the German Alzheimer Association and the Hirnliga.